Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 84 results.
User Information
Export Records
  1. 1.   Live attenuated rubella vectors expressing Plasmodium falciparum circumsporozoite protein (Pf-CSP) provide a novel malaria vaccine platform in the rhesus macaque
  2. Virnik, Konstantin; Zhou, Wenshuo; Medvedev, Alexei; Walsh, Gabrielle; Perry-Anderson, Jasper; Majam, Victoria; Felber,Barbara; Kumar, Sanjai; Berkower, Ira
  3. Biochemical and biophysical research communications. 2021, Nov 5; 577: 58-63.
  1. 2.   Advanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibody
  2. Lee, Myungeun; Lu, Zhi Hong; Shoemaker, Charles B.; Tremblay, Jacqueline M.; St Croix,Brad; Seaman,Steven; Gonzalez-Pastor, Rebeca; Kashentseva, Elena A.; Dmitriev, Igor P.; Curiel, David T.
  3. Journal of Controlled Release : Official Journal of the Controlled Release Society. 2021, Jun 10; 334: 106-113.
  1. 3.   Characterization of Cationic Bolaamphiphile Vesicles for siRNA Delivery into Tumors and Brain
  2. Kim, Taejin; Viard,Mathias; Afonin, Kirill A; Gupta, Kshitij; Popov, Mary; Salotti,Jacqueline; Johnson,Peter; Linder, Charles; Heldman, Eliahu; Shapiro,Bruce
  3. Molecular therapy. Nucleic acids. 2020, JUN 5; 20: 359-372.
  1. 4.   Anti-drug Antibody Responses Impair Prophylaxis Mediated by AAV-Delivered HIV-1 Broadly Neutralizing Antibodies
  2. Gardner, Matthew R.; Fetzer, Ina; Kattenhorn, Lisa M.; Davis-Gardner, Meredith E.; Zhou, Amber S.; Alfant, Barnett; Weber, Jesse A.; Kondur, Hema R.; Martinez-Navio, Jose M.; Fuchs, Sebastian P.; Desrosiers, Ronald C.; Gao, Guangping; Lifson,Jeffrey; Farzan, Michael
  3. Molecular therapy : the journal of the American Society of Gene Therapy. 2019, Mar 6; 27(3): 650-660.
  1. 5.   Expression of complete SIV p27 Gag and HIV gp120 engineered outer domains targeted by broadly neutralizing antibodies in live rubella vectors
  2. Virnik, Konstantin; Nesti, Edmund; Dail, Cody; Hockenbury, Max; Ni, Yisheng; Felber, Barbara; Schief, William R; Berkower, Ira
  3. Vaccine. 2017, May 31; 35(24): 3272-3278.
  1. 6.   Targeted Repair of CYBB in X-CGD iPSCs Requires Retention of Intronic Sequences for Expression and Functional Correction
  2. Sweeney, Colin L.; Zou, Jizhong; Choi, Uimook; Merling, Randall K.; Liu, Alexander; Bodansky, Aaron; Burkett, Sandra; Kim, Jung-Woong; De Ravin, Suk See; Malech, Harry L.
  3. MOLECULAR THERAPY. 2017, Feb 1; 25(2): 321-330.
  1. 7.   Protein delivery using engineered virus-like particles
  2. Kaczmarczyk, S. J.; Sitaraman, K.; Young, H. A.; Hughes, S. H.; Chatterjee, D. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, Oct; 108(41): 16998-17003.
  1. 8.   Mechanisms of Human Immunodeficiency Virus Type 2 RNA Packaging: Efficient trans Packaging and Selection of RNA Copackaging Partners
  2. Ni, N.; Nikolaitchik, O. A.; Dilley, K. A.; Chen, J. B.; Galli, A.; Fu, W.; Prasad, V.; Ptak, R. G.; Pathak, V. K.; Hu, W. S.
  3. Journal of Virology. 2011, Aug; 85(15): 7603-7612.
  1. 9.   A New Generation of Serotype Chimeric Infectivity-Enhanced Conditionally Replicative Adenovirals: The Safety Profile of Ad5/3-Delta 24 in Advance of a Phase I Clinical Trial in Ovarian Cancer Patients
  2. Kim, K. H.; Ryan, M. J.; Estep, J. E.; Miniard, B. M.; Rudge, T. L.; Peggins, J. O.; Broadt, T. L.; Wang, M. H.; Preuss, M. A.; Siegal, G. P.; Hemminki, A.; Harris, R. D.; Aurigemma, R.; Curiel, D. T.; Alvarez, R. D.
  3. Human Gene Therapy. 2011, Jul; 22(7): 821-828.
  1. 10.   Adeno-Associated Viral Vector-Mediated Transgene Expression Is Independent of DNA Methylation in Primate Liver and Skeletal Muscle
  2. Leger, A.; Le Guiner, C.; Nickerson, M. L.; Im, K. M.; Ferry, N.; Moullier, P.; Snyder, R. O.; Penaud-Budloo, M.
  3. Plos One. 2011, Jun; 6(6): 11.
  1. 11.   Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy
  2. Barsov, E. V.
  3. Immunotherapy. 2011, Mar; 3(3): 407-421.
  1. 12.   A Phase I Study of a Tropism-Modified Conditionally Replicative Adenovirus for Recurrent Malignant Gynecologic Diseases
  2. Kimball, K. J.; Preuss, M. A.; Barnes, M. N.; Wang, M. H.; Siegal, G. P.; Wan, W.; Kuo, H. C.; Saddekni, S.; Stockard, C. R.; Grizzle, W. E.; Harris, R. D.; Aurigemma, R.; Curiel, D. T.; Alvarez, R. D.
  3. Clinical Cancer Research. 2010, Nov; 16(21): 5277-5287.
  1. 13.   Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration
  2. Ferris, A. L.; Wu, X. L.; Hughes, C. M.; Stewart, C.; Smith, S. J.; Milne, T. A.; Wang, G. G.; Shun, M. C.; Allis, C. D.; Engelman, A.; Hughes, S. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2010, Feb 16; 107(7): 3135-3140.
  1. 14.   Partial protection against SIV challenge by vaccination of adenovirus and MVA vectors in rhesus monkeys
  2. Wang, H. B.; Kondo, A.; Yoshida, A.; Yoshizaki, S.; Abe, S.; Bao, L. L.; Mizuki, N.; Ichino, M.; Klinman, D.; Okuda, K.; Shimada, M.
  3. Gene Therapy. 2010, Jan; 17(1): 4-13.
  1. 15.   A rapid method for titrating baculovirus stocks using the Sf-9 Easy Titer cell line
  2. Hopkins, R. F.; Esposito, D.
  3. Biotechniques. 2009, Sep; 47(3): 785-788.
  1. 16.   Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5
  2. Abe, S.; Okuda, K.; Ura, T.; Kondo, A.; Yoshida, A.; Yoshizaki, S.; Mizuguchi, H.; Klinman, D.; Shimada, M.
  3. Journal of Gene Medicine. 2009 11(7): 570-579.
  1. 17.   Identifying the Safety Profile of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Anticipation of a Phase I Clinical Trial in Patients with Recurrent Ovarian Cancer
  2. Matthews, K.; Noker, P. E.; Tian, B. H.; Grimes, S. D.; Fulton, R.; Schweikart, K.; Harris, R.; Aurigemma, R.; Wang, M. H.; Barnes, M. N.; Siegal, G. P.; Hemminki, A.; Zinn, K.; Curiel, D. T.; Alvarez, R. D.
  3. Clinical Cancer Research. 2009 15(12): 4131-4137.
  1. 18.   Effect of therapeutic immunization using Ad5/35 and MVA vectors on SIV infection of rhesus monkeys undergoing antiretroviral therapy
  2. Shimada, M.; Wang, H. B.; Kondo, A.; Xu, X. P.; Yoshida, A.; Shinoda, K.; Ura, T.; Mizuguchi, H.; Klinman, D.; Luo, J. L.; Bai, H.
  3. Gene Therapy. 2009 16(2): 218-228.
  1. 19.   Gene targeting in mouse embryonic stem cells
  2. Tessarollo, L.; Palko, M. E.; Akagi, K.; Coppola, V.
  3. Methods in molecular biology (Clifton, N.J.). 2009 530: 141-164.
  1. 20.   Advantages of q-PCR as a method of screening for gene targeting in mammalian cells using conventional and whole BAC-based constructs
  2. Gomez-Rodriguez, J.; Washington, V.; Cheng, J.; Dutra, A.; Pak, E.; Liu, P. T.; McVicar, D. W.; Schwartzberg, P. L.
  3. Nucleic Acids Research. 2008 36(18): 1-9.
  1. 21.   Frequency and spectrum of genomic integration of recombinant adeno-associated virus serotype 8 vector in neonatal mouse liver
  2. Inagaki, K.; Piao, C. C.; Kotchey, N. M.; Wu, X. L.; Nakai, H.
  3. Journal of Virology. 2008 82(19): 9513-9524.
  1. 22.   Intersubunit disulfide isomerization controls membrane fusion of human T-cell leukemia virus Env
  2. Li, K. J.; Zhang, S. J.; Kronqvist, M.; Wallin, M.; Ekstrom, M.; Derse, D.; Garoff, H.
  3. Journal of Virology. 2008 82(14): 7135-7143.
  1. 23.   Requirement for the budding yeast polo kinase Cdc5 in proper microtubule growth and dynamics
  2. Park, C. J.; Park, J. E.; Karpova, T. S.; Soung, N. K.; Yu, L. R.; Song, S.; Lee, K. H.; Xia, X.; Kang, E.; Dabanoglu, I.; Oh, D. Y.; Zhang, J. Y.; Kang, Y. H.; Wincovitch, S.; Huffaker, T. C.; Veenstra, T. D.; McNally, J. G.; Lee, K. S.
  3. Eukaryotic Cell. 2008 7(3): 444-453.
  1. 24.   Filovirus-like particles produced in insect cells: Immunogenicity and protection in rodents
  2. Warfield, K. L.; Posten, N. A.; Swenson, D. L.; Olinger, G. G.; Esposito, D.; Gillette, W. K.; Hopkins, R. F.; Costantino, J.; Panchal, R. G.; Hartley, J. L.; Aman, M. J.; Bavari, S.
  3. Journal of Infectious Diseases. 2007, Nov; 196: S421-S429.
  1. 25.   Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid
  2. Boyer, J. D.; Robinson, T. M.; Kutzler, M. A.; Vansant, G.; Hokey, D. A.; Kumar, S.; Parkinson, R.; Wu, L.; Sidhu, M. K.; Pavlakis, G. N.; Felber, B. K.; Brown, C.; Silvera, P.; Lewis, M. G.; Monforte, J.; Waldmann, T. A.; Eldridge, J.; Weiner, D. B.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Nov; 104(47): 18648-18653.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel